Loading...

ImmunoGen, Inc.

IMGN•NASDAQ
Healthcare
Biotechnology
$31.23
$0.005(0.02%)

ImmunoGen, Inc. (IMGN) Stock Overview

Explore ImmunoGen, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 66.4/100

Key Financials

Market Cap8.7B
P/E Ratio-35.54
EPS (TTM)$-0.28
ROE-1.43%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$70.78

IMGN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ImmunoGen, Inc. (IMGN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $70.78.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -35.54 and a market capitalization of 8.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;